Report Detail
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2019-2024
- RnM2881503 |
- 05 February, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Other
23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.
23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.
North America is the largest supplier and consumption market of 23-Valent Pneumococcal Polysaccharide Vaccine, with a production market share nearly 70% and sales market share nearly 28% in 2015. Because Sanofipasteur, a competitor from Europe, transferred its vaccine type gradually, the production market share of North America in the world has enjoyed a dramatic increase.
The second place is EU, following North America with production market share of 15% and sales market share nearly 20% in 2015.China is another important market of 23-Valent Pneumococcal Polysaccharide Vaccine, enjoying 10% production market share and 15% sales market share in 2015.
According to this study, over the next five years the 23-Valent Pneumococcal Polysaccharide Vaccine market will register a 16.3% CAGR in terms of revenue, the global market size will reach US$ 3830 million by 2024, from US$ 1550 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in 23-Valent Pneumococcal Polysaccharide Vaccine business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of 23-Valent Pneumococcal Polysaccharide Vaccine market by product type, application, key manufacturers and key regions and countries.
This study considers the 23-Valent Pneumococcal Polysaccharide Vaccine value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Single Dose Vial
Pre-filled Syringe
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
For Children (2-10)
For Person (10-64)
For The Old (≥65)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
MSD
Sanofipasteur
CDIBP
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global 23-Valent Pneumococcal Polysaccharide Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of 23-Valent Pneumococcal Polysaccharide Vaccine market by identifying its various subsegments.
Focuses on the key global 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the 23-Valent Pneumococcal Polysaccharide Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of 23-Valent Pneumococcal Polysaccharide Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption 2014-2024
- 2.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Consumption CAGR by Region
- 2.2 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
- 2.2.1 Single Dose Vial
- 2.2.2 Pre-filled Syringe
- 2.3 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
- 2.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Type (2014-2019)
- 2.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Type (2014-2019)
- 2.4 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
- 2.4.1 For Children (2-10)
- 2.4.2 For Person (10-64)
- 2.4.3 For The Old (≥65)
- 2.5 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
- 2.5.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Market Share by Application (2014-2019)
- 2.5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Value and Market Share by Application (2014-2019)
- 2.5.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Application (2014-2019)
3 Global 23-Valent Pneumococcal Polysaccharide Vaccine by Players
- 3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Players
- 3.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Players (2017-2019)
- 3.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Players (2017-2019)
- 3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Players
- 3.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Players (2017-2019)
- 3.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Players (2017-2019)
- 3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sale Price by Players
- 3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players 23-Valent Pneumococcal Polysaccharide Vaccine Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 23-Valent Pneumococcal Polysaccharide Vaccine by Regions
- 4.1 23-Valent Pneumococcal Polysaccharide Vaccine by Regions
- 4.1.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Regions
- 4.1.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Value by Regions
- 4.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
- 4.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
- 4.4 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
- 4.5 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Growth
5 Americas
- 5.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
- 5.1.1 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2014-2019)
- 5.1.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2014-2019)
- 5.2 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
- 5.3 Americas 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries
- 6.1.1 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2014-2019)
- 6.1.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2014-2019)
- 6.2 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
- 6.3 APAC 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine by Countries
- 7.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2014-2019)
- 7.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2014-2019)
- 7.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
- 7.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine by Countries
- 8.1.1 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Value by Countries (2014-2019)
- 8.2 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Type
- 8.3 Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
- 10.3 23-Valent Pneumococcal Polysaccharide Vaccine Customer
11 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast
- 11.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast (2019-2024)
- 11.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions
- 11.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Regions (2019-2024)
- 11.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Type
- 11.8 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecast by Application
12 Key Players Analysis
- 12.1 MSD
- 12.1.1 Company Details
- 12.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
- 12.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 MSD News
- 12.2 Sanofipasteur
- 12.2.1 Company Details
- 12.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
- 12.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Sanofipasteur News
- 12.3 CDIBP
- 12.3.1 Company Details
- 12.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Offered
- 12.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 CDIBP News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on 23-Valent Pneumococcal Polysaccharide Vaccine . Industry analysis & Market Report on 23-Valent Pneumococcal Polysaccharide Vaccine is a syndicated market report, published as Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Growth 2019-2024. It is complete Research Study and Industry Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
